Cargando…
Development and validation of stability indicating method for the quantitative determination of venlafaxine hydrochloride in extended release formulation using high performance liquid chromatography
OBJECTIVE: Venlafaxine,hydrochloride is a structurally novel phenethyl bicyclic antidepressant, and is usually categorized as a serotonin–norepinephrine reuptake inhibitor (SNRI) but it has been referred to as a serotonin–norepinephrine–dopamine reuptake inhibitor. It inhibits the reuptake of dopami...
Autores principales: | Kaur, Jaspreet, Srinivasan, K. K., Joseph, Alex, Gupta, Abhishek, Singh, Yogendra, Srinivas, Kona S., Jain, Garima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146087/ https://www.ncbi.nlm.nih.gov/pubmed/21814426 http://dx.doi.org/10.4103/0975-7406.62701 |
Ejemplares similares
-
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015) -
Development and Validation of an Ultra Performance Liquid Chromatography Method for Venlafaxine Hydrochloride in Bulk and Capsule Dosage Form
por: Chhalotiya, U. K., et al.
Publicado: (2010) -
Modulation of Venlafaxine Hydrochloride Release from Press Coated Matrix Tablet
por: Gohel, M. C., et al.
Publicado: (2008) -
Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design
por: Khute, Sulekha, et al.
Publicado: (2023) -
Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
por: Patil, SA, et al.
Publicado: (2010)